ArticleRSC advances2026
DFT and solvent-phase insights into nitrosourea adsorption on AlN, GaN and their in-plane heterostructure (AlN/GaN) nanosheets.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is the second most common cause of death worldwide and its frequency is rising as the population grows. Nanotechnology has become a viable strategy for targeted cancer therapy in order to overcome these constraints in drug delivery. This study focuses on the adsorption behavior, electrical characteristics and drug-carrier interactions of the anticancer drug nitrosourea (NU) with pristine aluminum nitride (AlN) and gallium nitride (GaN) nanosheets along with their in-plane heterostructures (AlN/GaN (H1) and GaN/AlN (H2)) as efficient and selective potential nanocarriers for the delivery using density functional theory (DFT) in both air and water media. Our calculations showed that the NU adsorbed on AlN, AlN/GaN (H1), GaN and GaN/AlN (H2) with adsorption energies of -0.94, -0.74, -0.72, and -0.64 eV in air media and -0.75, -0.76, -0.51, and -0.36 eV in water media for the most stable complexes, respectively. After adsorption, the HOMO-LUMO energy gaps were reduced to be 3.84 to 1.87, 3.54 to 1.15, 3.37 to 2.07 and 3.54 to 2.18 eV for these nanosheets. The reduced HOMO-LUMO energy gap enhances the conductivity of the nanosheets and improved their applicability for electronic drug detection. The increased dipole moments and work function changes, mainly in water media following NU adsorption, indicate improved polarity and solubility. Furthermore, reactivity and stability were assessed using Conductor-like Screening Model (COSMO) surface and quantum molecular descriptor studies. According to our research, AlN and GaN based nanomaterials showed great promise as effective and selective NU carriers. Among them AlN in state 2 indicated their potential as effective nanocarriers for nitrosourea by exhibiting the best adsorption energy, electronic modulation and structural integrity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.